https://www.selleckchem.com/pr....oducts/act001-dmamcl
These results suggest that DUB3/KLF4 activation might be a potential therapeutic approach for HCC treatment.Aging inducing the development of senescent cells (SNCs) in various tissues is considered as the main cause of the age-related diseases. Senotherapy has become a promising anti-aging therapy. However, the effectivity and side-effect of senolytic agents are still concern. Here, we observed the downregulation of senescence-related genes by adoptive infusion of natural killer (NK) cells in 26 cases in peripheral blood CD3+ T ce
Like
Comment
Share
